Small-Molecule Drugs
Omeprazole
Last reviewed: 2026-11-19
Overview
A proton-pump inhibitor used in specific approved gastrointestinal medicines.
Regulatory status
FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.
Prilosec · Acid-related Disorders
Specified ulcers, reflux-related disease and pathological hypersecretory conditions; populations and combination regimens are label-specific.
Authoritative label record
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextEvidence at a glance
Controlled studies support specific acid-related indications; the evidence does not support unrelated general-health claims.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- Apomorphine
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Finasteride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Metformin
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Methylthioninium chloride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Minoxidil
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications